A lysine ring in HIV capsid pores coordinates IP6 to drive mature capsid assembly.


Journal

PLoS pathogens
ISSN: 1553-7374
Titre abrégé: PLoS Pathog
Pays: United States
ID NLM: 101238921

Informations de publication

Date de publication:
02 2021
Historique:
received: 22 07 2020
accepted: 13 11 2020
entrez: 1 2 2021
pubmed: 2 2 2021
medline: 24 6 2021
Statut: epublish

Résumé

The HIV capsid self-assembles a protective conical shell that simultaneously prevents host sensing whilst permitting the import of nucleotides to drive DNA synthesis. This is accomplished through the construction of dynamic, highly charged pores at the centre of each capsid multimer. The clustering of charges required for dNTP import is strongly destabilising and it is proposed that HIV uses the metabolite IP6 to coordinate the pore during assembly. Here we have investigated the role of inositol phosphates in coordinating a ring of positively charged lysine residues (K25) that forms at the base of the capsid pore. We show that whilst IP5, which can functionally replace IP6, engages an arginine ring (R18) at the top of the pore, the lysine ring simultaneously binds a second IP5 molecule. Dose dependent removal of K25 from the pore severely inhibits HIV infection and concomitantly prevents DNA synthesis. Cryo-tomography reveals that K25A virions have a severe assembly defect that inhibits the formation of mature capsid cones. Monitoring both the kinetics and morphology of capsids assembled in vitro reveals that while mutation K25A can still form tubes, the ability of IP6 to drive assembly of capsid cones has been lost. Finally, in single molecule TIRF microscopy experiments, capsid lattices in permeabilised K25 mutant virions are rapidly lost and cannot be stabilised by IP6. These results suggest that the coordination of IP6 by a second charged ring in mature hexamers drives the assembly of conical capsids capable of reverse transcription and infection.

Identifiants

pubmed: 33524070
doi: 10.1371/journal.ppat.1009164
pii: PPATHOGENS-D-20-01585
pmc: PMC7850482
doi:

Substances chimiques

DNA, Viral 0
Nucleotides 0
Phytic Acid 7IGF0S7R8I
Lysine K3Z4F929H6

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1009164

Subventions

Organisme : Wellcome Trust
ID : 214344/A/18/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : U105181010
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_U105181010
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 200594/Z/16/Z
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Nat Struct Mol Biol. 2011 Mar;18(3):295-301
pubmed: 21278753
J Virol. 2002 Jun;76(11):5667-77
pubmed: 11991995
Annu Rev Virol. 2014 Nov;1(1):561-80
pubmed: 26958734
Acta Crystallogr D Biol Crystallogr. 1997 May 1;53(Pt 3):240-55
pubmed: 15299926
Virology. 2011 Aug 15;417(1):137-46
pubmed: 21676426
Nature. 2016 Aug 18;536(7616):349-53
pubmed: 27509857
Science. 1996 Apr 12;272(5259):263-7
pubmed: 8602510
Elife. 2018 Jun 07;7:
pubmed: 29877795
Acta Crystallogr D Biol Crystallogr. 2007 Jan;63(Pt 1):32-41
pubmed: 17164524
Cell. 2009 Jun 26;137(7):1282-92
pubmed: 19523676
Elife. 2018 May 31;7:
pubmed: 29848441
Sci Adv. 2020 Sep 16;6(38):
pubmed: 32938668
ACS Appl Mater Interfaces. 2019 Sep 25;11(38):34586-34594
pubmed: 31483592
J Struct Biol. 2019 Aug 1;207(2):123-135
pubmed: 31059776
J Virol. 2013 Aug;87(16):9271-8
pubmed: 23785198
Science. 2020 Oct 9;370(6513):
pubmed: 33033190
PLoS Pathog. 2014 Oct 30;10(10):e1004459
pubmed: 25356722
Proc Natl Acad Sci U S A. 2011 Jun 14;108(24):9975-80
pubmed: 21628558
Nature. 2018 Aug;560(7719):509-512
pubmed: 30069050
PLoS Biol. 2020 Dec 17;18(12):e3001015
pubmed: 33332391
Retrovirology. 2012 Apr 19;9:30
pubmed: 22515365
Cell. 2007 Oct 5;131(1):70-9
pubmed: 17923088
Proc Natl Acad Sci U S A. 2020 Mar 10;117(10):5486-5493
pubmed: 32094182
Cell Rep. 2019 Dec 17;29(12):3983-3996.e4
pubmed: 31851928
J Virol. 1999 Feb;73(2):1460-7
pubmed: 9882352
Nat Microbiol. 2020 Sep;5(9):1088-1095
pubmed: 32483230
J Struct Biol. 2005 Oct;152(1):36-51
pubmed: 16182563
Nat Struct Mol Biol. 2009 Oct;16(10):1036-42
pubmed: 19767750
Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32
pubmed: 15572765
Langmuir. 2020 Apr 7;36(13):3624-3632
pubmed: 32212624
Acta Crystallogr D Biol Crystallogr. 2013 Jul;69(Pt 7):1204-14
pubmed: 23793146
Science. 2016 Dec 16;354(6318):1434-1437
pubmed: 27980210
Retrovirology. 2016 Aug 22;13(1):58
pubmed: 27549239
Nature. 2013 May 30;497(7451):643-6
pubmed: 23719463
J Synchrotron Radiat. 2003 Jan 1;10(Pt 1):23-5
pubmed: 12511787
mBio. 2019 Mar 12;10(2):
pubmed: 30862755
PLoS Pathog. 2013;9(6):e1003461
pubmed: 23818857
J Virol. 2003 May;77(9):5439-50
pubmed: 12692245
J Virol. 2004 Nov;78(21):12058-61
pubmed: 15479846
J Appl Crystallogr. 2009 Dec 1;42(Pt 6):1035-1042
pubmed: 22477774
Virology. 2014 Apr;454-455:371-9
pubmed: 24559861
Elife. 2016 Jun 02;5:
pubmed: 27253059
J Struct Biol. 1996 Jan-Feb;116(1):71-6
pubmed: 8742726

Auteurs

Nadine Renner (N)

MRC Laboratory of Molecular Biology, Cambridge, United Kingdom.

Donna L Mallery (DL)

MRC Laboratory of Molecular Biology, Cambridge, United Kingdom.

K M Rifat Faysal (KMR)

EMBL Australia Node in Single Molecule Science and ARC Centre of Excellence in Advanced Molecular Imaging, School of Medical Sciences, UNSW Sydney, Australia.

Wang Peng (W)

EMBL Australia Node in Single Molecule Science and ARC Centre of Excellence in Advanced Molecular Imaging, School of Medical Sciences, UNSW Sydney, Australia.

David A Jacques (DA)

EMBL Australia Node in Single Molecule Science and ARC Centre of Excellence in Advanced Molecular Imaging, School of Medical Sciences, UNSW Sydney, Australia.

Till Böcking (T)

EMBL Australia Node in Single Molecule Science and ARC Centre of Excellence in Advanced Molecular Imaging, School of Medical Sciences, UNSW Sydney, Australia.

Leo C James (LC)

MRC Laboratory of Molecular Biology, Cambridge, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH